BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26599517)

  • 1. A distinct expression profile separates Turkish and Australian melanocytic naevi.
    Fox C; Schaider H; Akalin T; Turkmen M; Sturm R; Lambie D; Karaarslan IK; Soyer HP; Ozdemir F; Gabrielli B
    Histopathology; 2016 Jul; 69(1):151-4. PubMed ID: 26599517
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma.
    Maiques O; Macià A; Moreno S; Barceló C; Santacana M; Vea A; Herreros J; Gatius S; Ortega E; Valls J; Chen BJ; Llobet-Navas D; Matias-Guiu X; Cantí C; Marti RM
    Br J Dermatol; 2017 May; 176(5):1247-1258. PubMed ID: 27718503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low positive predictive value of ABCD-E rule for dermatoscopy of small melanocytic naevi.
    Strumia R; Montanari A
    Melanoma Res; 2003 Dec; 13(6):631-2. PubMed ID: 14646628
    [No Abstract]   [Full Text] [Related]  

  • 5. A quantitative proteomic analysis of FFPE melanoma.
    Byrum S; Avaritt NL; Mackintosh SG; Munkberg JM; Badgwell BD; Cheung WL; Tackett AJ
    J Cutan Pathol; 2011 Nov; 38(11):933-6. PubMed ID: 21883366
    [No Abstract]   [Full Text] [Related]  

  • 6. Small cell melanoma.
    Kirkham N
    Histopathology; 2002 Feb; 40(2):196-8. PubMed ID: 11952866
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.
    Muchemwa FC; Nakatsura T; Fukushima S; Nishimura Y; Kageshita T; Ihn H
    Melanoma Res; 2008 Jun; 18(3):166-71. PubMed ID: 18477890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of COX-2 protein expression in melanocytic nevi in children].
    Kubus M; Andrzejewska E; Nejc D; Kobos J; Taran K
    Pol Merkur Lekarski; 2013 Aug; 35(206):82-4. PubMed ID: 24052986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of melanocytic proliferations.
    Prieto VG; Shea CR
    Arch Pathol Lab Med; 2011 Jul; 135(7):853-9. PubMed ID: 21732774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Four-color FISH probe in the diagnosis of melanocytic lesions.
    Boi S; Leonardi E; Fasanella S; Cantaloni C; Micciolo R
    J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1235-6. PubMed ID: 20236383
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell cycle inhibitor p27Kip1 in nevi and melanomas.
    Akman A; Ciftcioglu MA; Ozbey C; Alpsoy E
    Indian J Dermatol Venereol Leprol; 2008; 74(5):551. PubMed ID: 19068543
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
    Huber MA; Kraut N; Park JE; Schubert RD; Rettig WJ; Peter RU; Garin-Chesa P
    J Invest Dermatol; 2003 Feb; 120(2):182-8. PubMed ID: 12542520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadherin expression in melanocytic naevi and malignant melanomas.
    Cowley GP; Smith ME
    J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical characterization of Spitz's nevus: differentiation from common melanocytic nevus, dysplastic melanocytic nevus and malignant melanoma.
    Takahashi H; Maeda K; Maeda K; Akutsu Y; Horikoshi T; Jimbow K
    J Dermatol; 1987 Dec; 14(6):533-41. PubMed ID: 3329652
    [No Abstract]   [Full Text] [Related]  

  • 16. [The DNA and sex chromatin in pigmented skin neoplasms in man].
    Naleskina LA
    Vopr Onkol; 1971; 17(4):8-14. PubMed ID: 5564886
    [No Abstract]   [Full Text] [Related]  

  • 17. The PGF(2alpha) receptor FP is lost in nevi and melanoma.
    Fricke A; McClelland L; Scott G
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):141-3. PubMed ID: 20002888
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms.
    Ferrara G; Misciali C; Brenn T; Cerroni L; Kazakov DW; Perasole A; Russo R; Ricci R; Crisman G; Fanti PA; Passarini B; Patrizi A
    Int J Surg Pathol; 2013 Oct; 21(5):483-92. PubMed ID: 23775023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of S100A8 and PRAME as biomarkers for distinguishing melanoma from melanocytic naevus: a case-control analysis.
    Hai J; Meyer SN; Wong SL; Li Y; Simmons E; Miglioretti D; Fung MA; Kiuru M
    Clin Exp Dermatol; 2024 May; 49(6):584-590. PubMed ID: 38306117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated quantification of MART1-verified Ki-67 indices: useful diagnostic aid in melanocytic lesions.
    Nielsen PS; Spaun E; Riber-Hansen R; Steiniche T
    Hum Pathol; 2014 Jun; 45(6):1153-61. PubMed ID: 24704158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.